Alkermes (ALKS) EPS (Diluted) (2010 - 2026)
Alkermes (ALKS) EPS (Diluted) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.31 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 5.82 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.91 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.11 |
| 10 | Alkermes | 8.78 Bn | 8.27 Bn | 331.33 Mn | -0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.40 |
| Dec 31, 2025 | 0.57 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -0.02 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.25 |
| Mar 31, 2023 | -0.22 |
| Dec 31, 2022 | 0.54 |
| Sep 30, 2022 | -0.39 |
| Jun 30, 2022 | -0.18 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | 0.85 |
| Sep 30, 2021 | -0.18 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | -0.14 |
| Dec 31, 2020 | -0.19 |
| Sep 30, 2020 | 0.00 |